# OraSure Technologies, Inc. (OSUR) Stock Price, News & Analysis
Canonical URL: https://biopharmsignal.com/company/OSUR
## Company Profile
- Ticker: OSUR
- Exchange: NASDAQ
- Sector: MedTech
- Location: United States
- Tags: Diagnostics
## Stock Data
- Close: 3.88 USD
- Market cap: 275394212 USD
- Last updated: 2026-08-11
## Business Overview
### Decentralized Diagnostics
OraSure Technologies develops point-of-need and at-home diagnostic tests intended to make testing more accessible, private and convenient.
### Rapid-Test Portfolio
The company's products cover infectious diseases and other conditions across consumer, clinical, public-health and community settings. Subsidiaries including Sherlock Biosciences and BioMedomics broaden its diagnostic technologies.
### Sample-Management Solutions
DNA Genotek provides collection and stabilization devices for molecular testing, research and biobanking. These products allow biological samples to be collected outside traditional laboratories and transported without complex handling.
### Global Customer Base
OraSure sells to laboratories, hospitals, clinics, governments, research institutions, pharmaceutical companies and consumers, combining product sales with public-health and research demand.
## Why The Stock Is Moving

As of Aug 11, 2026, OSUR closed down 3.00% at $3.88. No new same-company headline was identified in the current news window.

## Recent News
- 2026-08-05 20:05 EST — [OraSure Announces Second Quarter 2026 Financial Results](https://biopharmsignal.com/news/OSUR/orasure-announces-second-quarter-2026-financial-results-c79a749f) — Source: OraSure Technologies, Inc.
- 2026-07-22 20:10 EST — [OraSure to Announce Second Quarter 2026 Financial Results and Host Earnings Call on August 5th](https://biopharmsignal.com/news/OSUR/orasure-to-announce-second-quarter-2026-financial-results-and-host-earnings-call-6dc566e7) — Source: OraSure Technologies, Inc.
- 2026-07-21 20:30 EST — [OraSure Receives Emergency Use Authorization for Second Generation Ebola Test](https://biopharmsignal.com/news/OSUR/orasure-receives-emergency-use-authorization-for-second-generation-ebola-test-aff25f4f) — Source: OraSure Technologies, Inc.
- 2026-06-11 12:00 EST — [OraSure Technologies, Inc. Announces FDA Clearance that Expands Patient‑Friendly Access to Testing for Sexually Transmitted Infections](https://biopharmsignal.com/news/OSUR/orasure-technologies-inc-announces-fda-clearance-that-expands-patient-friendly-a-af042dfa) — Source: OraSure Technologies, Inc.
- 2026-05-06 20:05 EST — [OraSure Announces First Quarter 2026 Financial Results](https://biopharmsignal.com/news/OSUR/orasure-announces-first-quarter-2026-financial-results) — Source: OraSure Technologies, Inc.